{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:53:34Z","timestamp":1789980814778,"version":"4.0.1"},"reference-count":40,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG010129"],"award-info":[{"award-number":["P30 AG010129"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["K01 AG030514"],"award-info":[{"award-number":["K01 AG030514"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2017.00281","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:02Z","timestamp":1494979202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Philip S.","family":"Insel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Gessert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1212\/WNL.0b013e3181c918b5","article-title":"\u03b2-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia","volume":"74","author":"Bourgeat","year":"2010","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and \u03b2-amyloid deposition in Alzheimer disease","volume":"67","author":"Ch\u00e9telat","year":"2010","journal-title":"Ann. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"B5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jalz.2014.11.002","article-title":"The transitional association between \u03b2-amyloid pathology and regional brain atrophy","volume":"11","author":"Insel","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1212\/WNL.0000000000002683","article-title":"Accelerating rates of cognitive decline and imaging markers associated with \u03b2-amyloid pathology","volume":"86","author":"Insel","year":"","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.dadm.2016.07.002","article-title":"Assessing risk for preclinical \u03b2-amyloid pathology with APOE, cognitive, and demographic information","volume":"4","author":"Insel","year":"","journal-title":"Alzheimers Dement. Diagnosis Assess. Dis. Monit."},{"key":"B9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimers Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1212\/01.wnl.0000435556.21319.e4","article-title":"Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity","volume":"81","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","article-title":"The Alzheimer's Disease neuroimaging initiative positron emission tomography core","volume":"6","author":"Jagust","year":"2010","journal-title":"Alzheimers Dement."},{"key":"B12","doi-asserted-by":"publisher","first-page":"18227","DOI":"10.1523\/JNEUROSCI.3266-12.2012","article-title":"Apolipoprotein E, not fibrillar \u03b2-amyloid, reduces cerebral glucose metabolism in normal aging","volume":"32","author":"Jagust","year":"2012","journal-title":"J. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/brain\/awu367","article-title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer's disease","volume":"138","author":"Mattsson","year":"2015","journal-title":"Brain A J. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2014.446","article-title":"Emerging \u03b2-Amyloid pathology and accelerated cortical atrophy","volume":"94121","author":"Mattsson","year":"2014","journal-title":"JAMA Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"Olsson","year":"2005","journal-title":"Clin. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET","volume":"39","author":"Ossenkoppele","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography","volume":"139","author":"Palmqvist","year":"2016","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer's disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J. Gerontol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/PMS.8.7.271-276","article-title":"Validity of the trail making test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept. Mot. Skills"},{"key":"B27","volume-title":"L'examen Cliniq ue en Psychologie","author":"Rey","year":"1958"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET Imaging of Tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B32","doi-asserted-by":"publisher","first-page":"228f","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-013-1151-4","article-title":"Longitudinal change in CSF Tau and A?? biomarkers for up to 48 months in ADNI","volume":"126","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/brain\/aws125","article-title":"Regional dynamics of amyloid-?? deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study","volume":"135","author":"Villain","year":"2012","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol."},{"key":"B37","volume-title":"Manual for Wechsler Memory Scale - Revised","author":"Wechsler","year":"1987"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/0028-3932(89)90186-3","article-title":"Boston naming test in Alzheimer's disease","volume":"27","author":"Williams","year":"1989","journal-title":"Neuropsychologia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1137\/0915069","article-title":"Monotonic smoothing splines fitted by cross validation","volume":"15","author":"Wood","year":"1994","journal-title":"SIAM"},{"key":"B40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1586\/14737175.2014.915740","article-title":"Understanding the cause of sporadic Alzheimer's disease","volume":"14","author":"Zetterberg","year":"2014","journal-title":"Expert Rev. Neurother."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:06Z","timestamp":1494979206000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":40,"alternative-id":["10.3389\/fnins.2017.00281"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2017.00281","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]},"article-number":"281"}}